ePlex Respiratory Panel molecular multiplex detection
GenMarkDx
ePlex - simple multiplex molecular testing.

ePlex RP

Respiratory Pathogen Panel

GenMark’s ePlex Respiratory Pathogen Panel (RP) detects and identifies the most common viral and bacterial organisms associated with upper respiratory infection.

ePlex Respiratory Panel molecular multiplex detection

EXCEED YOUR EXPECTATIONS

>20 common respiratory pathogens
Validated clinical performance
Rapid, accurate, actionable results
Improve patient outcome
Reduce the cost of care

Influenza is often the first pathogen that comes to mind with a respiratory infection, but many other virus and bacteria have a similar clinical presentation.

Comprehensive detection of the most common viral and bacterial pathogens ensures that each patient is given the most appropriate treatment quicker.

Due to the simplicity of the ePlex system it lends itself perfectly to point of care settings with only 2 minutes hands on time per sample.

 

Implementing ePlex Can:

Reduce the time the patient spends in ED or ICU waiting for a result

Optimise bed management with faster admission and discharge of patients based on results

Initiate targeted therapy quicker and reduce unnecessary use of antibiotics for viral infections

Streamline isolation protocols to prevent the spread of infection

Reduce confirmatory testing to identify the cause of infection

Comprehensive Coverage of the Most Common Respiratory Pathogens
Viral Targets

Adenovirus
Coronavirus 229E
Coronavirus HKU1
Coronavirus NL63
Coronavirus OC43
Middle East Respiratory
Syndrome Coronavirus (MERS-CoV)
Human Bocavirus
Human Metapneumovirus
Human Rhinovirus/Enterovirus
Influenza A
Influenza A H1
Influenza A H1-2009
Influenza A H3
Influenza B
Parainfluenza 1
Parainfluenza 2
Parainfluenza 3
Parainfluenza 4
Respiratory Syncytial Virus A
Respiratory Syncytial Virus B

Bacterial Targets

Bordetella pertussis
Chlamydia pneumoniae
Legionella pneumophila
Mycoplasma pneumoniae

GenMark Dx and ePlex are registered trademarks of GenMark Diagnostics Inc.